- Semler Scientific bought 455 BTC at $109,801 each, raising its total holdings to 4,264 coins worth $466 million this week.
- The firm funds Bitcoin purchases via stock offerings, issuing 3M shares under a $500M plan as SMLR stock fell 3.8% Friday.
Semler Scientific, a U.S.-listed healthcare technology firm, has purchased an additional $50 million worth of Bitcoin, raising its total holdings to 4,264 BTC. The company disclosed the transaction in a regulatory filing on Friday, confirming it acquired 455 BTC between May 13 and May 22 at an average price of $109,801 per coin. This marks its largest single purchase since adopting Bitcoin as a treasury reserve asset in May 2024.
The latest acquisition aligns with Bitcoin’s recent price rally, which saw the cryptocurrency briefly surpass $111,000 last week. Semler Scientific joins a small group of publicly traded companies, such as Strategy and Japan’s Metaplanet, that allocate corporate cash reserves to Bitcoin. To fund its purchases, the firm has relied on stock offerings, including a $500 million program announced in April. Over 3 million shares have been issued under this initiative, according to public records.
Semler Scientific first revealed its Bitcoin strategy one year ago, stating it would convert excess cash into the cryptocurrency. Its holdings, now valued at approximately $466 million, represent a 25.8% gain year-to-date based on its self-reported “Bitcoin Yield” metric. This performance mirrors trends seen at other firms using similar strategies, though Bitcoin’s price volatility remains a factor.
Shares of Semler Scientific (ticker: SMLR) closed 3.8% lower at $43.50 on Friday, giving the company a market value of $478 million. The stock has fluctuated alongside Bitcoin’s price movements in recent months, reflecting investor sentiment toward its treasury strategy.
Strategy, led by Michael Saylor, remains the largest corporate holder of Bitcoin with 576,230 BTC. Semler Scientific’s approach—using equity sales to fund crypto purchases—highlights a growing pattern among firms seeking exposure to digital assets without directly impacting operational budgets.
Semler Scientific’s trade underscores a pragmatic shift in how companies manage reserves. While risks persist, its repeated acquisitions suggest confidence in Bitcoin’s long-term role as a treasury asset.
